A carregar...
Lurasidone for the treatment of depressive symptoms in schizophrenia: analysis of 4 pooled, 6-week, placebo-controlled studies
OBJECTIVE: Depressive symptoms are common in schizophrenia and can worsen outcomes and increase suicide risk. Lurasidone is an atypical antipsychotic agent indicated for the treatment of schizophrenia and for the treatment of major depressive episodes associated with bipolar I disorder. This post ho...
Na minha lista:
| Publicado no: | CNS Spectr |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Cambridge University Press
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4411643/ https://ncbi.nlm.nih.gov/pubmed/24955752 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1017/S1092852914000285 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|